Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Mar 30, 2007 by Edgar Snyder

Parkinson’s Drug Permax Pulled from Market


The manufacturers of pergolide, sold as Permax and generic versions, have pulled the Parkinson’s drug due to significant risks of heart valve damage, and even death. The Food and Drug Administration (FDA) announced that Valeant Pharmaceuticals would voluntarily end the production and distribution of Permax. Companies Par and Teva will also cease manufacture of their generic brands.

Studies have shown that incidence of heart valve damage may occur in up to 23 percent of Permax and pergolide patients. Users of the medication should be aware that stopping use abruptly may be extremely dangerous. Instead, patients should consult their doctors to discuss alternative treatments to pergolide drugs.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "FDA Announces Voluntary Withdrawal of Pergolide Products." FDA Press Release. March 29, 2007.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Sep 14, 2016
PA Residents: You're This Much More Likely to Hit a Deer